•Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study
•Structural analysis of a soluble polysaccharide from the root of Atractylodis Macrocephala Rhizoma and its mechanism in alleviating ulcerative colitis in mice
•Epithelial barrier DUOX2 serves as early immune defense in intestinal pathogen control
•Population-based Real-World Adoption of Advanced Therapies for Ulcerative Colitis in Brazil: Trends and Regional Differences from a Nationwide Public Healthcare Database
•Schisantherin A alleviates DSS-induced colitis by upregulating ferredoxin 1 to inhibit inflammation and restore intestinal barrier function